Willing FDA Inspection

Jan 23, 2018

Rochem International and Jiangsu Willing BioTech Co., Ltd., a manufacturer of Veterinary API based in China, just had a week long FDA inspection in December 2017 as part of a Pre-Approval Inspection for the first API from Willing’s newest API site.  This is the first ever FDA inspection of that site and it was a success.  Robert Johnson, Sr. VP of Animal Health at Rochem, the regulatory, compliance, and commercial partner for Jiangsu Willing, said “We are very pleased with the result achieved during this FDA inspection.  I am very proud of what our partners at Jiangsu Willing and our team of compliance experts from the US and China have accomplished.  This is a key milestone for Jiangsu Willing to become a leading supplier of veterinary pharmaceutical ingredients.”  Willing’s product filings include Imidacloprid, Milbemycin Oxime, Moxidectin, and Selemectin.

Related Posts